Search

Your search keyword '"Carraro F"' showing total 454 results
Start Over Author "Carraro F"
454 results on '"Carraro F"'

2. Two Methods of Optimization for an AR Project: Mesh Retopology and Use of PBR Materials

Author

Perticarini, M., Callegaro, C., Carraro, F., Mazzariol, A., Kacprzyk, Janusz, Series Editor, Pal, Nikhil R., Advisory Editor, Bello Perez, Rafael, Advisory Editor, Corchado, Emilio S., Advisory Editor, Hagras, Hani, Advisory Editor, Kóczy, László T., Advisory Editor, Kreinovich, Vladik, Advisory Editor, Lin, Chin-Teng, Advisory Editor, Lu, Jie, Advisory Editor, Melin, Patricia, Advisory Editor, Nedjah, Nadia, Advisory Editor, Nguyen, Ngoc Thanh, Advisory Editor, Wang, Jun, Advisory Editor, and Cicalò, Enrico, editor

Published
2020
Full Text
View/download PDF

6. Experimental demonstration of free-space information transfer using phase modulated orbital angular momentum radio

Author

Tamburini, F., Thidé, B., Boaga, V., Carraro, F., del Pup, M., Bianchini, A., Someda, C. G., and Romanato, F.

Subjects
Physics - Classical Physics, Astrophysics - Instrumentation and Methods for Astrophysics, Physics - Optics, Physics - Space Physics
Abstract

In a series of fundamental proof-of-principle experiments, comprising numerical, controlled laboratory, and real-world experimentation, we have shown that it is possible to use the angular momentum physical layer for radio science and radio communication applications. Here we report a major, decisive step toward the realization of the latter, in the form of the real-world experimental demonstration that a radio beam carrying orbital angular momentum (OAM) can readily be digitally phase shift modulated and that the information thus encoded can be effectively transferred in free space to a remote receiver. The experiment was carried out in an urban setting and showed that the information transfer is robust against ground reflections and interfering radio signals. The importance of our results lies in the fact that digital phase shift keying (PSK) protocols are used in many present-day wireless communication scenarios, allowing new angular momentum radio implementations to use methods and protocols that are backward compatible with existing linear momentum ones., Comment: 7 pages, 3 figures. Corrected version

Published
2013

8. Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study

Author

Mukkada, S, Bhakta, N, Chantada, G, Chen, Y, Vedaraju, Y, Faughnan, L, Homsi, M, Muniz-Talavera, H, Ranadive, R, Metzger, M, Friedrich, P, Agulnik, A, Jeha, S, Lam, C, Dalvi, R, Hessissen, L, Moreira, D, Santana, V, Sullivan, M, Bouffet, E, Caniza, M, Devidas, M, Pritchard-Jones, K, Rodriguez-Galindo, C, Ribelles, A, Balduzzi, A, Elhaddad, A, Casanovas, A, Garcia Velazquez, A, Laptsevich, A, Chang, A, F. Sampaio A., L, Gonzalez Prieto, A, Lassaletta, A, Suarez M, A, Alcasabas, A, Colita, A, Morales La Madrid, A, Samudio, A, Tondo, A, Colombini, A, Kattamis, A, Lopez Facundo, N, Bhattacharyya, A, Alimi, A, Phulpin, A, Vakrmanova, B, Aksoy, B, Brethon, B, Kobuin, J, Nolasco Monteiro, C, Paillard, C, Vezina, C, Ceyhun, B, Hentea, C, Meazza, C, Ortiz-Morales, D, Solorzano, R, Arce Cabrera, D, Zama, D, Ghosh, D, Ramirez-Rivera, D, Calle Jara, D, Janic, D, Rey Helo, E, Gouache, E, Guerrero Quiroz, E, Lopez, E, Thebault, E, Maradiegue, E, de Berranger, E, Ebeid, F, Galaverna, F, Antillon-Klussmann, F, Espinoza Chacur, F, Negro, F, Carraro, F, Compagno, F, Barriga, F, Tamayo Pedraza, G, Sanchez Fernandez, G, Naidu, G, Tokuc, G, Alias, H, B Segocio, H, Boudiaf, H, Asetre Luna, I, Maia, I, Astigarraga, I, Maza, I, Montoya Vasquez, J, Jazbec, J, Lazic, J, Beck Dean, J, Rouger-Gaudichon, J, Contreras Gonzalez, J, Huerta Aragones, J, Fuster, J, Quintana, J, Palma, J, Svojgr, K, Quintero, K, Malic Tudor, K, Georgantzi, K, P Schultz, K, Urena Horno, L, Fraquelli, L, Meneghello, L, Shalaby, L, Macias Mora, L, A Renner, L, Nunes Silva, L, Sisinni, L, Hammad, M, Fernandez Sanmartin, M, Zubieta A, C, Drozdowski, M, Kourti, M, Palladino, M, Miranda Madrazo, M, Poiree, M, Popova, M, Melgar, M, Baragano, M, Aviles-Robles, M, Provenzi, M, Mendes Lins, M, Fatih Orhan, M, Villarroel, M, Jeronimo, M, Varas Palma, M, Rafie Raza, M, M Justin, M, Shaheen, N, Dominguez-Pinilla, N, Whipple, N, Andre, N, Hrusak, O, Velasco Puyo, P, Zacasa Vargas, P, Olate Mellado, P, Yola Gassant, P, Diaz Romero, P, De Santis, R, Kebudi, R, Boranbayeva, R, Vasquez, R, Segura, R, Rosado, R, Gomez, S, Raimbault, S, Gunasekera, S, Makkeyah, S, Buyukkapu Bay, S, M Gomez, S, Bouttefroy, S, Islam, S, Abouelnaga, S, Torres, S, Cesaro, S, Nunes, S, Rouxinol, S, Bhaumik, S, Saliyeva, S, Inostroza, T, Velasquez, T, Hnin, T, Noren-Nystrom, U, Baretta, V, Jimenez-Antolinez, Y, Perez Alonso, V, Ayer Miller, V, Gandemer, V, Lotero, V, Mishkova, V, Gomez-Garcia, W, Margaryan, Y, Syed, Y, Mukkada S., Bhakta N., Chantada G. L., Chen Y., Vedaraju Y., Faughnan L., Homsi M. R., Muniz-Talavera H., Ranadive R., Metzger M., Friedrich P., Agulnik A., Jeha S., Lam C., Dalvi R., Hessissen L., Moreira D. C., Santana V. M., Sullivan M., Bouffet E., Caniza M. A., Devidas M., Pritchard-Jones K., Rodriguez-Galindo C., Ribelles A. J., Balduzzi A., Elhaddad A., Casanovas A., Garcia Velazquez A., Laptsevich A., Chang A., F. Sampaio A. L., Gonzalez Prieto A., Lassaletta A., Suarez M A., Alcasabas A. P., Colita A., Morales La Madrid A., Samudio A., Tondo A., Colombini A., Kattamis A., Lopez Facundo N. A., Bhattacharyya A., Alimi A., Phulpin A., Vakrmanova B., Aksoy B. A., Brethon B., Kobuin J. B., Nolasco Monteiro C., Paillard C., Vezina C., Ceyhun B., Hentea C., Meazza C., Ortiz-Morales D., Solorzano R. D., Arce Cabrera D., Zama D., Ghosh D., Ramirez-Rivera D., Calle Jara D. A., Janic D., Rey Helo E., Gouache E., Guerrero Quiroz E., Lopez E., Thebault E., Maradiegue E., de Berranger E., Ebeid F. S. E., Galaverna F., Antillon-Klussmann F., Espinoza Chacur F., Negro F. D., Carraro F., Compagno F., Barriga F., Tamayo Pedraza G., Sanchez Fernandez G., Naidu G., Tokuc G., Alias H., B Segocio H. G., Boudiaf H., Asetre Luna I., Maia I., Astigarraga I., Maza I., Montoya Vasquez J. E., Jazbec J., Lazic J., Beck Dean J., Rouger-Gaudichon J., Contreras Gonzalez J. C., Huerta Aragones J., Fuster J. L., Quintana J., Palma J., Svojgr K., Quintero K., Malic Tudor K., Georgantzi K., P Schultz K. A., Urena Horno L., Fraquelli L., Meneghello L., Shalaby L., Macias Mora L. L., A Renner L., Nunes Silva L., Sisinni L., Hammad M., Fernandez Sanmartin M., Zubieta A C. M., Drozdowski M. C., Kourti M., Palladino M. M., Miranda Madrazo M. R., Poiree M., Popova M., Melgar M., Baragano M., Aviles-Robles M. J., Provenzi M., Mendes Lins M., Fatih Orhan M., Villarroel M., Jeronimo M., Varas Palma M., Rafie Raza M., M Justin M., Shaheen N., Dominguez-Pinilla N., Whipple N. S., Andre N., Hrusak O., Velasco Puyo P., Zacasa Vargas P., Olate Mellado P., Yola Gassant P., Diaz Romero P., De Santis R., Kebudi R., Boranbayeva R., Vasquez R., Segura R. A., Rosado R. E., Gomez S., Raimbault S., Gunasekera S., Makkeyah S. M., Buyukkapu Bay S., M Gomez S., Bouttefroy S., Islam S., Abouelnaga S., Torres S. F., Cesaro S., Nunes S., Rouxinol S., Bhaumik S., Saliyeva S., Inostroza T., Velasquez T., Hnin T. M., Noren-Nystrom U., Baretta V., Jimenez-Antolinez Y. V., Perez Alonso V., Ayer Miller V., Gandemer V., Lotero V., Mishkova V., Gomez-Garcia W., Margaryan Y., Syed Y., Mukkada, S, Bhakta, N, Chantada, G, Chen, Y, Vedaraju, Y, Faughnan, L, Homsi, M, Muniz-Talavera, H, Ranadive, R, Metzger, M, Friedrich, P, Agulnik, A, Jeha, S, Lam, C, Dalvi, R, Hessissen, L, Moreira, D, Santana, V, Sullivan, M, Bouffet, E, Caniza, M, Devidas, M, Pritchard-Jones, K, Rodriguez-Galindo, C, Ribelles, A, Balduzzi, A, Elhaddad, A, Casanovas, A, Garcia Velazquez, A, Laptsevich, A, Chang, A, F. Sampaio A., L, Gonzalez Prieto, A, Lassaletta, A, Suarez M, A, Alcasabas, A, Colita, A, Morales La Madrid, A, Samudio, A, Tondo, A, Colombini, A, Kattamis, A, Lopez Facundo, N, Bhattacharyya, A, Alimi, A, Phulpin, A, Vakrmanova, B, Aksoy, B, Brethon, B, Kobuin, J, Nolasco Monteiro, C, Paillard, C, Vezina, C, Ceyhun, B, Hentea, C, Meazza, C, Ortiz-Morales, D, Solorzano, R, Arce Cabrera, D, Zama, D, Ghosh, D, Ramirez-Rivera, D, Calle Jara, D, Janic, D, Rey Helo, E, Gouache, E, Guerrero Quiroz, E, Lopez, E, Thebault, E, Maradiegue, E, de Berranger, E, Ebeid, F, Galaverna, F, Antillon-Klussmann, F, Espinoza Chacur, F, Negro, F, Carraro, F, Compagno, F, Barriga, F, Tamayo Pedraza, G, Sanchez Fernandez, G, Naidu, G, Tokuc, G, Alias, H, B Segocio, H, Boudiaf, H, Asetre Luna, I, Maia, I, Astigarraga, I, Maza, I, Montoya Vasquez, J, Jazbec, J, Lazic, J, Beck Dean, J, Rouger-Gaudichon, J, Contreras Gonzalez, J, Huerta Aragones, J, Fuster, J, Quintana, J, Palma, J, Svojgr, K, Quintero, K, Malic Tudor, K, Georgantzi, K, P Schultz, K, Urena Horno, L, Fraquelli, L, Meneghello, L, Shalaby, L, Macias Mora, L, A Renner, L, Nunes Silva, L, Sisinni, L, Hammad, M, Fernandez Sanmartin, M, Zubieta A, C, Drozdowski, M, Kourti, M, Palladino, M, Miranda Madrazo, M, Poiree, M, Popova, M, Melgar, M, Baragano, M, Aviles-Robles, M, Provenzi, M, Mendes Lins, M, Fatih Orhan, M, Villarroel, M, Jeronimo, M, Varas Palma, M, Rafie Raza, M, M Justin, M, Shaheen, N, Dominguez-Pinilla, N, Whipple, N, Andre, N, Hrusak, O, Velasco Puyo, P, Zacasa Vargas, P, Olate Mellado, P, Yola Gassant, P, Diaz Romero, P, De Santis, R, Kebudi, R, Boranbayeva, R, Vasquez, R, Segura, R, Rosado, R, Gomez, S, Raimbault, S, Gunasekera, S, Makkeyah, S, Buyukkapu Bay, S, M Gomez, S, Bouttefroy, S, Islam, S, Abouelnaga, S, Torres, S, Cesaro, S, Nunes, S, Rouxinol, S, Bhaumik, S, Saliyeva, S, Inostroza, T, Velasquez, T, Hnin, T, Noren-Nystrom, U, Baretta, V, Jimenez-Antolinez, Y, Perez Alonso, V, Ayer Miller, V, Gandemer, V, Lotero, V, Mishkova, V, Gomez-Garcia, W, Margaryan, Y, Syed, Y, Mukkada S., Bhakta N., Chantada G. L., Chen Y., Vedaraju Y., Faughnan L., Homsi M. R., Muniz-Talavera H., Ranadive R., Metzger M., Friedrich P., Agulnik A., Jeha S., Lam C., Dalvi R., Hessissen L., Moreira D. C., Santana V. M., Sullivan M., Bouffet E., Caniza M. A., Devidas M., Pritchard-Jones K., Rodriguez-Galindo C., Ribelles A. J., Balduzzi A., Elhaddad A., Casanovas A., Garcia Velazquez A., Laptsevich A., Chang A., F. Sampaio A. L., Gonzalez Prieto A., Lassaletta A., Suarez M A., Alcasabas A. P., Colita A., Morales La Madrid A., Samudio A., Tondo A., Colombini A., Kattamis A., Lopez Facundo N. A., Bhattacharyya A., Alimi A., Phulpin A., Vakrmanova B., Aksoy B. A., Brethon B., Kobuin J. B., Nolasco Monteiro C., Paillard C., Vezina C., Ceyhun B., Hentea C., Meazza C., Ortiz-Morales D., Solorzano R. D., Arce Cabrera D., Zama D., Ghosh D., Ramirez-Rivera D., Calle Jara D. A., Janic D., Rey Helo E., Gouache E., Guerrero Quiroz E., Lopez E., Thebault E., Maradiegue E., de Berranger E., Ebeid F. S. E., Galaverna F., Antillon-Klussmann F., Espinoza Chacur F., Negro F. D., Carraro F., Compagno F., Barriga F., Tamayo Pedraza G., Sanchez Fernandez G., Naidu G., Tokuc G., Alias H., B Segocio H. G., Boudiaf H., Asetre Luna I., Maia I., Astigarraga I., Maza I., Montoya Vasquez J. E., Jazbec J., Lazic J., Beck Dean J., Rouger-Gaudichon J., Contreras Gonzalez J. C., Huerta Aragones J., Fuster J. L., Quintana J., Palma J., Svojgr K., Quintero K., Malic Tudor K., Georgantzi K., P Schultz K. A., Urena Horno L., Fraquelli L., Meneghello L., Shalaby L., Macias Mora L. L., A Renner L., Nunes Silva L., Sisinni L., Hammad M., Fernandez Sanmartin M., Zubieta A C. M., Drozdowski M. C., Kourti M., Palladino M. M., Miranda Madrazo M. R., Poiree M., Popova M., Melgar M., Baragano M., Aviles-Robles M. J., Provenzi M., Mendes Lins M., Fatih Orhan M., Villarroel M., Jeronimo M., Varas Palma M., Rafie Raza M., M Justin M., Shaheen N., Dominguez-Pinilla N., Whipple N. S., Andre N., Hrusak O., Velasco Puyo P., Zacasa Vargas P., Olate Mellado P., Yola Gassant P., Diaz Romero P., De Santis R., Kebudi R., Boranbayeva R., Vasquez R., Segura R. A., Rosado R. E., Gomez S., Raimbault S., Gunasekera S., Makkeyah S. M., Buyukkapu Bay S., M Gomez S., Bouttefroy S., Islam S., Abouelnaga S., Torres S. F., Cesaro S., Nunes S., Rouxinol S., Bhaumik S., Saliyeva S., Inostroza T., Velasquez T., Hnin T. M., Noren-Nystrom U., Baretta V., Jimenez-Antolinez Y. V., Perez Alonso V., Ayer Miller V., Gandemer V., Lotero V., Mishkova V., Gomez-Garcia W., Margaryan Y., and Syed Y.

Abstract

Background: Previous studies have shown that children and adolescents with COVID-19 generally have mild disease. Children and adolescents with cancer, however, can have severe disease when infected with respiratory viruses. In this study, we aimed to understand the clinical course and outcomes of SARS-CoV-2 infection in children and adolescents with cancer. Methods: We did a cohort study with data from 131 institutions in 45 countries. We created the Global Registry of COVID-19 in Childhood Cancer to capture de-identified data pertaining to laboratory-confirmed SARS-CoV-2 infections in children and adolescents (<19 years) with cancer or having received a haematopoietic stem-cell transplantation. There were no centre-specific exclusion criteria. The registry was disseminated through professional networks through email and conferences and health-care providers were invited to submit all qualifying cases. Data for demographics, oncological diagnosis, clinical course, and cancer therapy details were collected. Primary outcomes were disease severity and modification to cancer-directed therapy. The registry remains open to data collection. Findings: Of 1520 submitted episodes, 1500 patients were included in the study between April 15, 2020, and Feb 1, 2021. 1319 patients had complete 30-day follow-up. 259 (19·9%) of 1301 patients had a severe or critical infection, and 50 (3·8%) of 1319 died with the cause attributed to COVID-19 infection. Modifications to cancer-directed therapy occurred in 609 (55·8%) of 1092 patients receiving active oncological treatment. Multivariable analysis revealed several factors associated with severe or critical illness, including World Bank low-income or lower-middle-income (odds ratio [OR] 5·8 [95% CI 3·8–8·8]; p<0·0001) and upper-middle-income (1·6 [1·2–2·2]; p=0·0024) country status; age 15–18 years (1·6 [1·1–2·2]; p=0·013); absolute lymphocyte count of 300 or less cells per mm3 (2·5 [1·8–3·4]; p<0·0001), absolute neutrophil count

Published
2021

9. Combining a genetically engineered oxidase with hydrogen-bonded organic frameworks (HOFs) for highly efficient biocomposites

Author

Wied, P., Carraro, F., Bolívar Bolívar, Juan Manuel, Doonan, C.J., Falcaro, P., Nidetzky, B., Wied, P., Carraro, F., Bolívar Bolívar, Juan Manuel, Doonan, C.J., Falcaro, P., and Nidetzky, B.

Abstract

Enzymes incorporated into hydrogen-bonded organic frameworks (HOFs) via bottom-up synthesis are promising biocomposites for applications in catalysis and sensing. Here, we explored synthetic incorporation of d-amino acid oxidase (DAAO) with the metal-free tetraamidine/tetracarboxylate-based BioHOF-1 in water. N-terminal enzyme fusion with the positively charged module Zbasic2 strongly boosted the loading (2.5-fold; ≈500 mg enzyme gmaterial−1) and the specific activity (6.5-fold; 23 U mg−1). The DAAO@BioHOF-1 composites showed superior activity with respect to every reported carrier for the same enzyme and excellent stability during catalyst recycling. Further, extension to other enzymes, including cytochrome P450 BM3 (used in the production of high-value oxyfunctionalized compounds), points to the versatility of genetic engineering as a strategy for the preparation of biohybrid systems with unprecedented properties.

Published
2022

10. Spectroscopic Characterization of Mineralogy and Its Diversity Across Vesta

Author

De Sanctis, M. C., Ammannito, E., Capria, M. T., Tosi, F., Capaccioni, F., Zambon, F., Carraro, F., Fonte, S., Frigeri, A., Jaumann, R., Magni, G., Marchi, S., McCord, T. B., McFadden, L. A., McSween, H. Y., Mittlefehldt, D. W., Nathues, A., Palomba, E., Pieters, C. M., Raymond, C. A., Russell, C. T., Toplis, M. J., and Turrini, D.

Published
2012
Full Text
View/download PDF

12. The Surface Composition and Temperature of Asteroid 21 Lutetia As Observed by Rosetta/VIRTIS

Author

Coradini, A., Capaccioni, F., Erard, S., Arnold, G., De Sanctis, M. C., Filacchione, G., Tosi, F., Barucci, M. A., Capria, M. T., Ammannito, E., Grassi, D., Piccioni, G., Giuppi, S., Bellucci, G., Benkhoff, J., Bibring, J. P., Blanco, A., Blecka, M., Bockelee-Morvan, D., Carraro, F., Carlson, R., Carsenty, U., Cerroni, P., Colangeli, L., Combes, M., Combi, M., Crovisier, J., Drossart, P., Encrenaz, E. T., Federico, C., Fink, U., Fonti, S., Giacomini, L., Ip, W. H., Jaumann, R., Kuehrt, E., Langevin, Y., Magni, G., McCord, T., Mennella, V., Mottola, S., Neukum, G., Orofino, V., Palumbo, P., Schade, U., Schmitt, B., Taylor, F., Tiphene, D., and Tozzi, G.

Published
2011

15. Olivine in an unexpected location on Vesta’s surface

Author

Ammannito, E., De Sanctis, M. C., Palomba, E., Longobardo, A., Mittlefehldt, D. W., McSween, H. Y., Marchi, S., Capria, M. T., Capaccioni, F., Frigeri, A., Pieters, C. M., Ruesch, O., Tosi, F., Zambon, F., Carraro, F., Fonte, S., Hiesinger, H., Magni, G., McFadden, L. A., Raymond, C. A., Russell, C. T., and Sunshine, J. M.

Published
2013
Full Text
View/download PDF

17. Safety and efficacy of brincidofovir for Adenovirus infection in children receiving allogeneic stem cell transplantation: an AIEOP retrospective analyses

Author

Perruccio, K., Menconi, M., Galaverna, F., Pagliara, D., Carraro, F., Fagioli, F., Calore, E., Biffi, A., Baretta, V., Massei, M. S., Capolsini, I., Faraci, M., Verna, M., Soncini, E., Caniglia, M., Locatelli, Franco, and Cesaro, S.

Subjects
Oncology, medicine.medical_specialty, allogeneic stem cell transpantaiton, Adenoviridae Infections, MEDLINE, Organophosphonates, Brincidofovir, allogeneic stem cell transpantaiton, adenovirus infection, Antiviral Agents, ADENOVIRUS, adenovirus infection, Cytosine, Internal medicine, medicine, Humans, Adenovirus infection, Retrospective Studies, Transplantation, business.industry, Hematopoietic Stem Cell Transplantation, Hematology, medicine.disease, Settore MED/38 - PEDIATRIA GENERALE E SPECIALISTICA, HSCT, Stem cell, brincidofovir, business, medicine.drug
Published
2021

19. Phase dependent encapsulation and release profile of ZIF-based biocomposites

Author

Carraro, F., Velásquez-Hernández, M. de J., Astria, E., Liang, W., Twight, L., Parise, C., Ge, M., Huang, Zhehao, Ricco, R., Zou, Xiaodong, Villanova, L., Kappe, C. O., Doonan, C., Falcaro, P., Carraro, F., Velásquez-Hernández, M. de J., Astria, E., Liang, W., Twight, L., Parise, C., Ge, M., Huang, Zhehao, Ricco, R., Zou, Xiaodong, Villanova, L., Kappe, C. O., Doonan, C., and Falcaro, P.

Abstract

Biocomposites composed of Zeolitic Imidazolate Frameworks (ZIFs) are generating significant interest due to their facile synthesis, and capacity to protect proteins from harsh environments. Here we systematically varied the composition (i.e. relative amounts of ligand (2-methylimidazole), metal precursor (Zn(OAc)(2)center dot 2H(2)O), and protein) and post synthetic treatments (i.e. washes with water or water/ethanol) to prepare a series of protein@ZIF biocomposites. These data were used to construct two ternary phase diagrams that showed the synthesis conditions employed gave rise to five different phases including, for the first time, biocomposites based on ZIF-CO3-1. We examined the influence of the different phases on two properties relevant to drug delivery applications: encapsulation efficiency and release profile. The encapsulation efficiencies of bovine serum albumin and insulin were phase dependent and ranged from 75% to 100%. In addition, release profiles showed that 100% protein release varied between 40 and 300 minutes depending on the phase. This study provides a detailed compositional map for the targeted preparation of ZIF-based biocomposites of specific phases and a tool for the straightforward analysis of the crystalline phases of ZIF based materials (web application named ZIF phase analysis). These data will facilitate the progress of ZIF bio-composites in the fields of biomedicine and biotechnology.

Published
2020
Full Text
View/download PDF

21. Mineralogical Composition of the Different Types of Bright Deposits on Vesta

Author

Zambon, F, Capaccioni, F, DeSanctis, M. C, Ammannito, E, Li, J.-Y, Longobardo, A, Mittlefehldt, D. W, Palomba, E, Pieters, C. M, Schroeder, S. E, Tosi, F, Hiesinger, H, Blewett, D. T, Russell, C. T, Raymond, C. A, Capria, M. T, Carraro, F, Fonte, S, Frigeri, A, and Magni, G

Subjects
Geophysics
Abstract

VIR-MS, Dawn's Visible and Infrared Mapping Spectrometer, obtained hyperspectral images of a wide part of Vesta's surface at a variety of spatial resolutions [1]. Vesta spectra are similar to those of the howardite-eucrite-diogenite (HED) meteorites. Moreover, they are characterized by the two iron-bearing pyroxene bands at 0.9 (band I) and 1.9 microns (band II). Vesta surface's is dominated by eucrite/howardite with some diogenitic regions situated in the southern hemisphere near the Rheasilvia basin [2]. The surface is heavily craterized and impacts can expose fresh material, thus generating the Bright Material Deposits (BMD) observed within and surrounding certain craters. BMD can be classified into six different types based on their morphological characteristics: Crater Wall/Scarp Material (CWM), Radial Material (RM), Slope Material (SM), Patchy Material (PM), Spot Material (SpM) and Diffuse Plains Material (DPM) [3]. The most widespread BMD are CWM, SM and RM. CWM, SM, RM originate from impacts. CWM is situated on the edge of the craters. Mass wasting from the crater walls and generates the SM, while RM is associated with the ejecta of the craters [4]. BMD are characterized by albedo greater than that of the vestan average, 0.38 [5]. Therefore the different types of deposits present distinct levels of reflectance respect to the Surrounding Regions (SR), in particular: the CWM and SM is approx.40% brighter, the RM is approx.30- 40% brighter; the SpM is about 20-25% brighter and the PM is about 20% brighter. Near the edge of the Rheasilvia basin it is possible to find some extremely bright areas ~80% brighter than the vestan average [6].

Published
2013

24. Phase dependent encapsulation and release profile of ZIF-based biocomposites

Author

Carraro, F., primary, Velásquez-Hernández, M. de J., additional, Astria, E., additional, Liang, W., additional, Twight, L., additional, Parise, C., additional, Ge, M., additional, Huang, Z., additional, Ricco, R., additional, Zou, X., additional, Villanova, L., additional, Kappe, C. O., additional, Doonan, C., additional, and Falcaro, P., additional

Published
2020
Full Text
View/download PDF

25. Vesta Mineralogy after Dawn Global Observations

Author

ChristinaDeSanctis, Maria, Ammannito, E, Capaccioni, F, Cparia, M. T, Carraro, F, Fonte, S, Frigeri, A, Longobardo, A, Marchi, S, Palomba, E, Tosi, F, Zambon, F, Combe, J. P, McCord, T. B, McFadden, L. A, McSween, H, Mittlefehldt, D. W, Pieters, C. M, Jaumann, R, Stephan, K, Raymond, C. A, and Russell, C. T

Subjects
Astrophysics
Abstract

The Dawn mission has completed its mapping phases at Vesta and millions of spectra have been acquired by the Visible and InfraRed Mapping Spectrometer, VIR(1). VIR characterizes and maps the mineral distribution on Vesta -strengthening the Vesta HED linkage- and provides new insights into Vesta s formation and evolution(2,3). VIR spectra are dominated by pyroxene absorptions near 0.9 and 2.0 m and large thermal emission beyond 3.5 m. Although almost all surface materials exhibit howardite-like spectra, some large regions can be interpreted to be richer in eucritic (basaltic) material and others richer in diogenititic (Mg-orthopyroxenitic) material. The Rheasilvia basin contains Mg-pyroxene-rich terrains for example. Vesta' s surface shows considerable diversity at local scales. Many bright and dark areas(3,4) are associated with various geological features and show remarkably different morphology. Moreover, VIR detected statistically significant, but weak, variations at 2.8 m that have been interpreted as indicating the presence of OH-bearing phases on the surface(5). The OH distribution is uneven with large regions lacking this absorption feature. Associations of 2.8 m band with morphological structures indicate complex process responsible for OH. Vesta exhibits large spectral variations that often correlate with geological structures, indicating a complex geological and evolutionary history, more similar to that of the terrestrial planets than to other asteroids visited by spacecrafts.

Published
2012

26. Spectroscopic Characterization of Mineralogy Across Vesta: Evidence of Different Lithologies

Author

De Sanotis, M. C, Ammannito, E, Filacchione, G, Capria, M. T, Tosi, F, Capaccioni, F, Zambon, F, Carraro, F, Fonte, S, Frigeri, A, Jaumann, R, Magni, G, Marchi, S, McCord, T. B, McFadden, L. A, McSween, H. Y, Mittlefehldt, D. W, Nathues, A, Palomba, E, Pieters, C. M, Raymond, C. A, Russell, C. T, and Turrini, D

Subjects
Geophysics
Abstract

The average spectrum of Vesta, obtained by VIR in the range 0.25-5.1 microns, shows clear evidence of absorption bands due to pyroxenes and thermal emissions beyond 3.5 11m. Vesta shows considerable variability across its surface in terms of spectral reflectance and emission, band depths, bands widths and bands centers, reflecting a complex geological history. Vesta's average spectrum and inferred mineralogy resemble those of howardite meteorites. On a regional scale, significant deviations are seen: the south polar 500km Rheasilvia impact crater has a higher diogenitic component, and equatorial regions show a higher eucritic component. This lithologic distribution, with a concentration of Mg-pyroxenes in the Rheasilvia area, reinforces the hypothesis of a deeper diogenitic crust excavated by the impact that formed the Rheasilvia crater, and an upper eucritic crust, whose remnants are seen in the equatorial region. This scenario has implications for Vesta differentiation, consistent with magma ocean models. However, serial magmatism models could also have concentrated pyroxene cumulates in plutons emplaced within the lower crust

Published
2012

27. Characterization of Mineralogy Across Vesta

Author

De Sanctis, M. C, Ammannito, E, Capria, M. T, Capaccioni, F, Carraro, F, Fonte, S, Frigeri, A, Magni, G, Marchi, S, Palomba, E, Tosi, F, Zambon, F, McCord, T. B, McFadden, L. A, McSween, H, Mittlefehldt, D. W, Pieters, C. M, Raymond, C. A, and Russell, C. T

Subjects
Geophysics
Abstract

Dawn VIR spectra are characterized by pyroxene absorptions and no clear evidence for abundant other minerals are observed at the scale of the present measurements. Even though Vesta spectra are dominated by pyroxenes, spectral variation at regional and local scales are evident and distinct color units are identified. Although almost all of the surface materials exhibit spectra like those of howardites, some large units can be interpreted to be material richer in diogenite (based on pyroxenes band depths and band centers) and some others like eucrite-rich howardite units. VIR data strongly indicate that the south polar region (Rheasilvia) has its own spectral characteristics, indicating the presence of Mg-pyroxene-rich terrains (diogenite-like), while the equatorial areas have swallower band depths and average band centers at slightly longer wavelengths, consistent with more eucrite rich materials. Vesta surface shows considerable diversity at smaller scales (tens of km), in terms of spectral reflectance and emission, band depths and slopes. Many bright and dark spots are present on Vesta. Dark spots have low reflectance at visible wavelengths and are spectrally characterized by shallower 1 and 2 micron bands with respect the surrounding terrains. Bright materials have high reflectance and are often spectrally characterized by deep pyroxenes absorption bands. Vesta presents complex geology/topography and the mineral distribution is often correlated with geological and topographical structures. Ejecta from large craters have distinct spectral behaviors, and materials exposed in the craters show distinct spectra on floors and rims. VIR reveals the mineralogical variation of Vesta s crustal stratigraphy on local and global scales. Maps of spectral parameters show surface and subsurface unit compositions in their stratigraphic context. The hypothesis that Vesta is the HED parent body is consistent with, and strengthened by, the geologic and spectral context for pyroxene distribution provided by Dawn.

Published
2012

28. Overview of Vesta Mineralogy Diversity

Author

DeSanctis, M. C, Ammannito, E, Capria, M. T, Capaccioni, F, Carraro, F, Fonte, S, Frigeri, A, Magni, G, Marchi, S, Palomba, E, Tosi, F, Zambon, F, McCord, T. B, McFadden, L. A, McSween, H, Mittlefehldt, D. W, Pieters, C. M, Raymond, C. A, and Russell, C. T

Subjects
Geophysics
Abstract

4 Vesta is known to have a surface of basaltic material through visible/near-infrared reflectance spectroscopy (1). Vesta s spectrum has strong absorption features centered near 0.9 and 1.9 m, indicative of Fe-bearing pyroxenes. The spectra of HED (howardite, eucrite and diogenite) meteorites have similar features (1). This led to the hypothesis that Vesta was the parent body of the HED clan (2,3) and the discovery of a dynamical Vesta family of asteroids (Vestoids) provides a further link between Vesta and HEDs (4). Data from the Dawn VIR (Visible InfraRed mapping Spectrometer) (5) characterize and map the mineral distribution on Vesta, strengthen the Vesta - HED linkage and provide new insights into Vesta s formation and evolution.

Published
2012

29. Dawn Maps the Surface Composition of Vesta

Author

Prettyman, T, Palmer, E, Reedy, R, Sykes, M, Yingst, R, McSween, H, DeSanctis, M. C, Capaccinoni, F, Capria, M. T, Filacchione, G, Magni, G, Ammannito, E, Carraro, F, Coradini, A, Fonte, S, Noschese, R, Tosi, F, Blewett, D, Denevi, B, Lawrence, D, Buratti, B, Raymond, C. A, Combe, J. P, McCord, T, and Forni, O

Subjects
Lunar And Planetary Science And Exploration
Abstract

By 7-October-2011, the Dawn mission will have completed Survey orbit and commenced high altitude mapping of 4-Vesta. We present a preliminary analysis of data acquired by Dawn's Framing Camera (FC) and the Visual and InfraRed Spectrometer (VIR) to map mineralogy and surface temperature, and to detect and quantify surficial OH. The radiometric calibration of VIR and FC is described. Background counting data acquired by GRaND are used to determine elemental detection limits from measurements at low altitude, which will commence in November. Geochemical models used in the interpretation of the data are described. Thermal properties, mineral-, and geochemical-data are combined to provide constraints on Vesta s formation and thermal evolution, the delivery of exogenic materials, space weathering processes, and the origin of the howardite, eucrite, and diogenite (HED) meteorites.

Published
2011

30. Vesta Mineralogy: VIR maps Vesta's surface

Author

Coradina, A, DeSanctis, M, Ammannito, E, Capaccioni, F, Capria, T, Carraro, F, Cartacci, M, Filacchione, G, Fonte, S, Magni, G, Noschese, R, Tosi, F, Barucci, A, Federico, C, Frigeri, A, Fulchigoni, M, Langevin, Y, Marchi, S, Palomba, E, Turrini, D, McCord, T, McFadden, L. A, Pieters, C, Raymond, C. A, and Russell, C. T

Subjects
Geophysics
Abstract

The Dawn mission will have completed Survey orbit around 4 Vesta by the end of August 2011. We present a preliminary analysis of data acquired by the Visual and InfraRed Spectrometer (VIR) to map Vesta mineralogy. Thermal properties and mineralogical data are combined to provide constraints on Vesta's formation and thermal evolution. delivery of exogenic materials, space weathering processes, and origin of the howardite. eucrite, and diogenite (HED) meteorites.

Published
2011

32. Lo spazio marino

Author

Carraro, F. and Metelli, M. C.

Subjects
archeologia del Mediterraneo, urbanistica antica, archeologia costiera, archeologia fenicio-punica, archeologia, archeologia romana, archeologia, archeologia romana, archeologia fenicio-punica, archeologia costiera, archeologia del Mediterraneo, urbanistica antica
Published
2018

33. New geomorphological and chronological constraints for glacial deposits in the Rivoli-Avigliana end-moraine system and the lower Susa Valley (Western Alps, NW Italy)

Author

Ivy-Ochs S., Lucchesi S., Baggio P., Fioraso G., Gianotti F., Monegato G., Graf A.A., Akcar N., Christl M., Carraro F., Forno M.G., and Schluchter C.

Subjects
Last Glacial Maximum, cosmogenic 10Be, moraine amphitheatre, European Alps, exposure dating
Abstract

Our new dataset from the Rivoli-Avigliana end-moraine system, the westernmost amphitheatre of the Italian Alps, provides an important step towards understanding foreland-reaching glaciations before and during the Last Glacial Maximum (LGM) in the Western Alps. 10Be data from six boulders in pre-LGM deposits gave ages between 26.82.1 and 41.21.9 ka. Based on morphological and pedological data, we interpret the oldest age as a minimum age for the glacier advance(s). 10Be results suggest that the LGM occurred in two major steps. During the first at 24.01.5 ka, several ridges were constructed demonstrating oscillation of the Dora Riparia glacier snout at the maximum position. Our data demonstrate a significantly larger LGM extent in the Rivoli- Avigliana amphitheatre than shown on previous maps. The maximum advance was followed by a short re-advance of the glacier at 19.60.9 ka, as recorded by 10Be ages from boulders in lateral positions along the lower Susa Valley. The maximum ice surface during the LGM was at 1000-920m a.s.l. in the final reach of the valley (560- 620m of elevation above the alluvial plain) and at 620-340m a.s.l. at the continuous moraines in the amphitheatre.

Published
2018
Full Text
View/download PDF

35. Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey

Author

Girmenia, C, Bertaina, A, Piciocchi, A, Perruccio, K, Algarotti, A, Busca, A, Cattaneo, C, Raiola, Am, Guidi, S, Iori, Ap, Candoni, A, Irrera, G, Milone, G, Marcacci, G, Scimè, R, Musso, M, Cudillo, L, Sica, S, Castagna, L, Corradini, P, Marchesi, F, Pastore, D, Alessandrino, Ep, Annaloro, C, Ciceri, F, Santarone, S, Nassi, L, Farina, C, Viscoli, C, Rossolini, Gm, Bonifazi, F, Rambaldi, A, Capria, S, Mastronuzzi, A, Pagliara, D, Bernaschi, P, Amico, L, Carotti, A, Mencacci, A, Bruno, B, Costa, C, Passi, A, Ravizzola, G, Angelucci, E, Marchese, A, Pecile, P, Ventura, G, Fanin, R, Scarparo, C, Barbaro, A, Leotta, S, Marchese, Ae, Becchimanzi, C, Donnarumma, D, Tringali, S, Baldi, Mt, Scalone, R, Picardi, A, Arcese, W, Fontana, C, Giammarco, S, Spanu, T, Crocchiolo, R, Casari, E, Mussetti, A, Conte, E, Ensoli, F, Miragliotta, G, Marone, P, Arghittu, M, Greco, R, Forcina, A, Chichero, P, Di Bartolomeo, P, Fazii, P, Kroumova, V, Decembrino, N, Zecca, M, Pisapia, G, Palazzo, G, Lanino, E, Faraci, M, Castagnola, E, Bandettini, R, Pastano, R, Sammassimo, S, Passerini, R, Stefani, Pm, Gherlinzoni, F, Rigoli, R, Prezioso, L, Cambò, B, Calderaro, A, Carella, Am, Cascavilla, N, Labonia, Mt, Celeghini, I, Mordini, N, Piana, F, Vacca, A, Sanna, M, Podda, G, Corsetti, Mt, Rocchetti, A, Cilloni, D, De Gobbi, M, Bianco, O, Fagioli, F, Carraro, F, De Intinis, G, Severino, A, Proia, A, Parisi, G, Vallisa, D, Confalonieri, M, Russo, D, Malagola, M, Galieni, P, Falcioni, S, Travaglini, V, Raimondi, R, Borghero, C, Pavan, G, Prete, A, Belotti, T, Ambretti, S, Imola, M, Mianulli, Am, Pedna, Mf, Cesaro, S, Lo Cascio, G, Ferrari, A, Piedimonte, M, Santino, I, Calandrelli, M, Olivieri, A, Orecchioni, F, Mirabile, M, Centurioni, R, Gironacci, L, Caravelli, D, Gallo, S, De Filippi, M, Cupelli, L, Dentamaro, T, Falco, S, Eugenio, Os, Marotta, S, Risitano, A, Lula, D, Musto, P, Pietrantuono, G, Traficante, A, Cerchiara, E, Tirindelli, Mc, Dicuonzo, G, Chierichini, A, Anaclerico, B, and Placanica, P.

Published
2017

37. DIFFERENTIAL INFLUENCE OF HYPOXIA ON GENE EXPRESSION OF TUMORAL AND NON TUMORAL MAMMARY CELLS

Author

Albanese, N., DI CARA, G., Musso, R., Cancemi, P., Filippi, I., Carraro, F., PUCCI MINAFRA, I., ALBANESE, NN, DI CARA, G, MUSSO, R, CANCEMI, P, FILIPPI, I, CARRARO, F, and PUCCI-MINAFRA, I.

Subjects
HYPOXIA, BREAST CANCER
Abstract

Cancer metastasis is the result of a series of deregulated biological phenomena, including alterations of cell-cell and cell-matrix interactions and of other microenvironmental conditions such as the oxygen tissue supply. Hypoxia is a well-known driver of aggressive cancer phenotypes, indeed tumors with poor prognosis have higher proportions of anoxic and hypoxic areas1. The consequences of tumour hypoxia can be local or even systemic towards distant organs, and it can evoke diversified responses: whereas low oxygen concentration in tissue environments. (pO2

Published
2015

41. A prospective, multicentre survey on antifungal therapy in neutropenic paediatric haematology patients

Author

Cesaro, Simone, Pagano, L, Caira, M, Carraro, F, Luciani, M, Russo, D, Colombini, A, Morello, W, Viale, P, Rossi, G, Tridello, G, Pegoraro, A, Nosari, A, Aversa, F., Cesaro S, Pagano L, Caira M, Carraro F, Luciani M, Russo D, Colombini A, Morello W, Viale P, Rossi G, Tridello G, Pegoraro A, Nosari A, Aversa F, Cesaro, S, Pagano, L, Caira, M, Carraro, F, Luciani, M, Russo, D, Colombini, A, Morello, W, Viale, P, Rossi, G, Tridello, G, Pegoraro, A, Nosari, A, and Aversa, F

Subjects
Male, Antifungal Agents, Neutropenia, Adolescent, FEBRILE NEUTROPIA, Humans, Prospective Studies, fungal infection, therapy, febrile neutropenia, Child, Antifungal therapy, therapy, invasive mycose, Leukemia, fungal infection, Lymphoma, Non-Hodgkin, Infant, Settore MED/15 - MALATTIE DEL SANGUE, febrile neutropenia, Infectious Diseases, pediatric, Paediatric malignancy, fungal, Child, Preschool, Acute Disease, Female
Abstract

Invasive fungal infections are a frequent complication after intensive chemotherapy. The aims of this prospective study were to describe the use of antifungal therapy and to report which strategy was routinely adopted to guide the introduction of antifungal therapy. A total of 321 febrile episodes in 160 paediatric patients affected by acute leukaemia or non-Hodgkin-lymphoma were investigated. Antifungal therapy was used in 100 of 321 febrile episodes (31%), and classified as empiric in 73 episodes, diagnostic-driven in 25 episodes and targeted in 2 episodes. Switching to a second-line antifungal therapy was needed in 28 of 100 episodes (28%) and was classified as empiric in 10 episodes (36%), diagnostic-driven in 17 episodes (61%) and targeted in 1 episode (4%). In 9 of 28 episodes (32%), switching to a third-line antifungal therapy was performed and was classified as empiric in 2 episodes (22%), diagnostic-driven in 6 episodes (67%) and targeted in 1 episode (11%). Invasive fungal infections was reported in 23 of 100 episodes: confirmed in 4 episodes, probable in 8 episodes, and possible in 11 episodes. Attributable mortality was 2.8%. Antifungal therapy was still used mostly empirically, whereas as fever persisted, its modification was guided by a diagnostic-driven approach. © 2012 Blackwell Verlag GmbH

Published
2012

43. Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia after Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey

Author

Girmenia, C., Bertaina, A., Piciocchi, A., Perruccio, K., Algarotti, A., Busca, A., Cattaneo, C., Raiola, A. M., Guidi, S., Iori, A. P., Candoni, A., Irrera, G., Milone, G., Marcacci, G., Scime, R., Musso, M., Cudillo, L., Sica, Simona, Castagna, Luigi, Corradini, P., Marchesi, F., Pastore, D., Alessandrino, E. P., Annaloro, C., Ciceri, F., Santarone, S., Nassi, L., Farina, C., Viscoli, C., Rossolini, G. M., Bonifazi, F., Rambaldi, A., Capria, S., Mastronuzzi, A., Pagliara, D., Bernaschi, P., Amico, L., Carotti, A., Mencacci, A., Bruno, Brunella, Costa, C., Passi, A., Ravizzola, G., Angelucci, E., Marchese, Alessandra Maria, Pecile, P., Ventura, Giulio, Fanin, R., Scarparo, C., Barbaro, A., Leotta, Salvatore Nuccio, Marchese, A. E., Becchimanzi, C., Donnarumma, D., Tringali, S., Baldi, M. T., Scalone, R., Picardi, A., Arcese, W., Fontana, Cecilia Alejandra, Giammarco, S., Spanu, Teresa, Crocchiolo, R., Casari, E., Mussetti, A., Conte, Eliana, Ensoli, F., Miragliotta, G., Marone, P., Arghittu, M., Greco, R., Forcina, A., Chichero, P., Di Bartolomeo, P., Fazii, P., Kroumova, V., Decembrino, N., Zecca, M., Pisapia, Giovanni, Palazzo, G., Lanino, E., Faraci, M., Castagnola, E., Bandettini, R., Pastano, R., Sammassimo, S., Passerini, R., Stefani, P. M., Gherlinzoni, F., Rigoli, R., Prezioso, L., Cambo, B., Calderaro, A., Carella, A. M., Cascavilla, N., Labonia, M. T., Celeghini, I., Mordini, N., Piana, F., Vacca, A., Sanna, Maria Maddalena, Podda, G., Corsetti, M. T., Rocchetti, A., Cilloni, D., De Gobbi, M., Bianco, O., Fagioli, F., Carraro, F., De Intinis, G., Severino, A., Proia, Anna Silvia, Parisi, G., Vallisa, D., Confalonieri, Marco, Russo, D., Malagola, M., Galieni, P., Falcioni, S., Travaglini, V., Raimondi, Maria Rosa, Borghero, C., Pavan, Giuseppe, Prete, A., Belotti, T., Ambretti, S., Imola, M., Mianulli, A. M., Pedna, M. F., Cesaro, S., Lo Cascio, G., Ferrari, A., Piedimonte, M., Santino, I., Calandrelli, M., Olivieri, Alessandra, Orecchioni, F., Mirabile, M., Centurioni, R., Gironacci, L., Caravelli, D., Gallo, S., De Filippi, M., Cupelli, L., Dentamaro, T., Falco, S., Eugenio, O. S., Marotta, S., Risitano, A., Lula, D., Musto, P., Pietrantuono, G., Traficante, A., Cerchiara, E., Tirindelli, M. C., Dicuonzo, G., Chierichini, A., Anaclerico, B., Placanica, P., Sica S. (ORCID:0000-0003-2426-3465), Castagna L., Bruno B., Marchese A., Ventura G. (ORCID:0000-0002-0304-7264), Leotta S., Fontana C., Spanu T. (ORCID:0000-0003-1864-5184), Conte E., Pisapia G., Sanna M., Proia A., Confalonieri M. (ORCID:0000-0002-3708-379X), Raimondi R., Pavan G., Olivieri A., Girmenia, C., Bertaina, A., Piciocchi, A., Perruccio, K., Algarotti, A., Busca, A., Cattaneo, C., Raiola, A. M., Guidi, S., Iori, A. P., Candoni, A., Irrera, G., Milone, G., Marcacci, G., Scime, R., Musso, M., Cudillo, L., Sica, Simona, Castagna, Luigi, Corradini, P., Marchesi, F., Pastore, D., Alessandrino, E. P., Annaloro, C., Ciceri, F., Santarone, S., Nassi, L., Farina, C., Viscoli, C., Rossolini, G. M., Bonifazi, F., Rambaldi, A., Capria, S., Mastronuzzi, A., Pagliara, D., Bernaschi, P., Amico, L., Carotti, A., Mencacci, A., Bruno, Brunella, Costa, C., Passi, A., Ravizzola, G., Angelucci, E., Marchese, Alessandra Maria, Pecile, P., Ventura, Giulio, Fanin, R., Scarparo, C., Barbaro, A., Leotta, Salvatore Nuccio, Marchese, A. E., Becchimanzi, C., Donnarumma, D., Tringali, S., Baldi, M. T., Scalone, R., Picardi, A., Arcese, W., Fontana, Cecilia Alejandra, Giammarco, S., Spanu, Teresa, Crocchiolo, R., Casari, E., Mussetti, A., Conte, Eliana, Ensoli, F., Miragliotta, G., Marone, P., Arghittu, M., Greco, R., Forcina, A., Chichero, P., Di Bartolomeo, P., Fazii, P., Kroumova, V., Decembrino, N., Zecca, M., Pisapia, Giovanni, Palazzo, G., Lanino, E., Faraci, M., Castagnola, E., Bandettini, R., Pastano, R., Sammassimo, S., Passerini, R., Stefani, P. M., Gherlinzoni, F., Rigoli, R., Prezioso, L., Cambo, B., Calderaro, A., Carella, A. M., Cascavilla, N., Labonia, M. T., Celeghini, I., Mordini, N., Piana, F., Vacca, A., Sanna, Maria Maddalena, Podda, G., Corsetti, M. T., Rocchetti, A., Cilloni, D., De Gobbi, M., Bianco, O., Fagioli, F., Carraro, F., De Intinis, G., Severino, A., Proia, Anna Silvia, Parisi, G., Vallisa, D., Confalonieri, Marco, Russo, D., Malagola, M., Galieni, P., Falcioni, S., Travaglini, V., Raimondi, Maria Rosa, Borghero, C., Pavan, Giuseppe, Prete, A., Belotti, T., Ambretti, S., Imola, M., Mianulli, A. M., Pedna, M. F., Cesaro, S., Lo Cascio, G., Ferrari, A., Piedimonte, M., Santino, I., Calandrelli, M., Olivieri, Alessandra, Orecchioni, F., Mirabile, M., Centurioni, R., Gironacci, L., Caravelli, D., Gallo, S., De Filippi, M., Cupelli, L., Dentamaro, T., Falco, S., Eugenio, O. S., Marotta, S., Risitano, A., Lula, D., Musto, P., Pietrantuono, G., Traficante, A., Cerchiara, E., Tirindelli, M. C., Dicuonzo, G., Chierichini, A., Anaclerico, B., Placanica, P., Sica S. (ORCID:0000-0003-2426-3465), Castagna L., Bruno B., Marchese A., Ventura G. (ORCID:0000-0002-0304-7264), Leotta S., Fontana C., Spanu T. (ORCID:0000-0003-1864-5184), Conte E., Pisapia G., Sanna M., Proia A., Confalonieri M. (ORCID:0000-0002-3708-379X), Raimondi R., Pavan G., and Olivieri A.

Abstract

Background Gram-negative bacteremia (GNB) is a major cause of illness and death after hematopoietic stem cell transplantation (HSCT), and updated epidemiological investigation is advisable. Methods We prospectively evaluated the epidemiology of pre-engraftment GNB in 1118 allogeneic HSCTs (allo-HSCTs) and 1625 autologous HSCTs (auto-HSCTs) among 54 transplant centers during 2014 (SIGNB-GITMO-AMCLI study). Using logistic regression methods. we identified risk factors for GNB and evaluated the impact of GNB on the 4-month overall-survival after transplant. Results The cumulative incidence of pre-engraftment GNB was 17.3% in allo-HSCT and 9% in auto-HSCT. Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa were the most common isolates. By multivariate analysis, variables associated with GNB were a diagnosis of acute leukemia, a transplant from a HLA-mismatched donor and from cord blood, older age, and duration of severe neutropenia in allo-HSCT, and a diagnosis of lymphoma, older age, and no antibacterial prophylaxis in auto-HSCT. A pretransplant infection by a resistant pathogen was significantly associated with an increased risk of posttransplant infection by the same microorganism in allo-HSCT. Colonization by resistant gram-negative bacteria was significantly associated with an increased rate of infection by the same pathogen in both transplant procedures. GNB was independently associated with increased mortality at 4 months both in allo-HSCT (hazard ratio, 2.13; 95% confidence interval, 1.45-3.13; P <.001) and auto-HSCT (2.43; 1.22-4.84; P =.01). Conclusions Pre-engraftment GNB is an independent factor associated with increased mortality rate at 4 months after auto-HSCT and allo-HSCT. Previous infectious history and colonization monitoring represent major indicators of GNB. Clinical Trials registration NCT02088840.

Published
2017

44. Single-day trimethoprim/sulfamethoxazole prophylaxis for pneumocystis pneumonia in children with cancer

Author

Caselli, D, Petris, Mg, Rondelli, R, Carraro, F, Colombini, A, Muggeo, P, Ziino, Melchionda, F, Russo, G, Pierani, P, Soncini, E, Desantis, R, Zanazzo, G, Barone, A, Cesaro, Simone, Cellini, M, Mura, R, Milano, Gm, Meazza, C, Cicalese, Mp, Tropia, S, De Masi, S, Castagnola, E, Aricò, M, Infectious Diseases Working Group of the Associazione Italiana Ematologia Oncologia Pediatrica, Caselli, D, Petris, Mg, Rondelli, R, Carraro, F, Colombini, A, Muggeo, P, Ziino, O, Melchionda, F, Russo, G, Pierani, P, Soncini, E, Desantis, R, Zanazzo, G, Barone, A, Cesaro, S, Cellini, M, Mura, R, Milano, Gm, Meazza, C, Cicalese, Mp, Tropia, S, De Masi, S, Castagnola, E, Aricò, M, and Infectious Diseases Working Group of the Associazione Italiana Ematologia Oncologia, Pediatrica.

Subjects
medicine.medical_specialty, Pneumocystis carinii, Pneumocystis pneumonia, Drug Administration Schedule, Anti-Infective Agents, Internal medicine, Trimethoprim, Sulfamethoxazole Drug Combination, medicine, Humans, Cumulative incidence, Prospective Studies, Child, Prospective cohort study, Intention-to-treat analysis, Dose-Response Relationship, Drug, business.industry, Pneumocystis (jirovecii [carinii]) pneumonia (PCP), Incidence, Pneumonia, Pneumocystis, Sulfamethoxazole, trimethoprim/sulfamethoxazole, prophylaxis against PCP, medicine.disease, Trimethoprim, Surgery, Pneumonia, Regimen, Treatment Outcome, Italy, Hematologic Neoplasms, Pediatrics, Perinatology and Child Health, business, Follow-Up Studies, medicine.drug
Abstract

Objective To determine whether a simplified, 1-day/week regimen of trimethoprim/sulfamethoxazole is sufficient to prevent Pneumocystis (jirovecii [carinii]) pneumonia (PCP). Current recommended regimens for prophylaxis against PCP range from daily administration to 3 consecutive days per week dosing. Study design A prospective survey of the regimens adopted for the PCP prophylaxis in all patients treated for childhood cancer at pediatric hematology-oncology centers of the Associazione Italiana Ematologia Oncologia Pediatrica. Results The 20 centers participating in the study reported a total of 2466 patients, including 1093 with solid tumor and 1373 with leukemia/lymphoma (or primary immunodeficiency; n = 2). Of these patients, 1371 (55.6%) received the 3-day/week prophylaxis regimen, 406 (16.5%) received the 2-day/week regimen, and 689 (27.9%), including 439 with leukemia/lymphoma, received the 1-day/week regimen. Overall, only 2 cases of PCP (0.08%) were reported, both in the 2-day/week group. By intention to treat, the cumulative incidence of PCP at 3 years was 0.09% overall (95% CI, 0.00-0.40%) and 0.51% for the 2-day/week group (95% CI, 0.10%-2.00%). Remarkably, both patients who failed had withdrawn from prophylaxis. Conclusion A single-day course of prophylaxis with trimethoprim/sulfamethoxazole may be sufficient to prevent PCP in children with cancer undergoing intensive chemotherapy regimens. This simplified strategy might have implications for the emerging need for PCP prophylaxis in other patients subjected to the increased use of biological and nonbiological agents that induce higher levels of immune suppression, such as those with rheumatic diseases.

Published
2014

46. Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy

Author

Girmenia, C, Rossolini, Gm, Piciocchi, A, Bertaina, A, Pisapia, G, Pastore, D, Sica, S, Severino, A, Cudillo, L, Ciceri, F, Scimè, R, Lombardini, L, Viscoli, C, Rambaldi, A, the Gruppo Italiano Trapianto Midollo Osseo (GITMO), Frigeni, M, Corti, C, Mometto, G, Annaloro, C, Casari, E, Castagna, L, Rossi, G, Cattaneo, C, Russo, D, Cancelli, V, Alessandrino, Ep, Ripamonti, F, Pavan, F, Rovelli, A, Pecoraro, C, Busca, A, Carraro, F, Fagioli, F, Gallo, S, Caravelli, D, De Gobbi, M, Saglio, G, Castellino, C, Mordini, N, Gaidano, G, Nassi, L, Raimondi, R, Vespignani, M, Scattolin, Am, Panizzolo, Is, Cesaro, S, Candoni, A, Patriarca, F, Bacigalupo, A, Raiola, A, Castagnola, E, Lanino, E, Stanzani, M, Bandini, G, Massaccesi, E, Prete, A, Bassi, S, Vallisa, D, Caramatti, C, Aversa, F, Zuffa, E, Guidi, S, Bosi, A, Tintori, V, Iori, Ap, Capria, S, Arcese, W, Dentamaro, T, Fabritiis, Pd, Anaclerico, B, Chierichini, A, Piedimonte, M, Ferrari, A, Marchesi, F, Mengarelli, A, Cerchiara, E, Tirindelli, Mc, Gaziev, J, Majolino, I, Chiusolo, P, Lucarelli, B, Massei, Ms, Carotti, A, Perruccio, K, Caniglia, M, Santarone, S, Bartolomeo, Pd, Mazzotta, S, Galieni, P, Olivieri, A, Rosa, Gd, Risitano, A, Delia, M, Specchia, G, Palazzo, G, Messina, G, Irrera, G, Angelucci, E, Baronciani, D, Vacca, A, Crescimanno, A, Musso, M, Imbriani, A, Milone, G., Girmenia, C, Rossolini, Gm, Piciocchi, A, Bertaina, A, Pisapia, G, Pastore, D, Sica, S, Severino, A, Cudillo, L, Ciceri, Fabio, Scime, R, Lombardini, L, Viscoli, C, Rambaldi, A, and and the Gruppo Italiano Trapianto Midollo Osseo, (GITMO)

Subjects
Male, Klebsiella pneumoniae, Carbapenem resistant Klebsiella pneumoniae, Drug Resistance, carbapenem-resistant Klebsiella pneumoniae, colonization, sepsis, Allogeneic Hematopoietic Stem Cell Transplantation, Hematologic Diseases, hemic and lymphatic diseases, polycyclic compounds, Medicine, Adolescent, Adult, Aged, Allografts, Autografts, Female, Humans, Italy, Klebsiella Infections, Middle Aged, Retrospective Studies, Carbapenems, Drug Resistance, Bacterial, Stem Cell Transplantation, Hematology, Transplantation, biology, Bacterial, humanities, surgical procedures, operative, medicine.medical_specialty, Retrospective survey, Internal medicine, business.industry, Retrospective cohort study, Klebsiella infections, biology.organism_classification, Settore MED/15, infection, body regions, Settore MED/15 - MALATTIE DEL SANGUE, Immunology, business
Abstract

Infections by carbapenem-resistant Klebsiella pneumoniae (CRKp) represent a challenging problem after SCT. A retrospective survey (January 2010 to July 2013) involving 52 Italian centers was performed to assess the epidemiology and the prognostic factors of CRKp infections in auto- and allo-SCT. Cases of CRKp infection were reported in 53.4% of centers. CRKp infections were documented in 25 auto-SCTs and 87 allo-SCTs, with an incidence of 0.4% (from 0.1% in 2010 to 0.7% in 2013) and 2% (from 0.4% in 2010 to 2.9% in 2013), respectively. A CRKp colonization documented before or after transplant was followed by an infection in 25.8% of auto-SCT and 39.2% of allo-SCT patients. The infection-related mortality rates were 16% and 64.4%, respectively. A pre-transplant CRKp infection (hazard ratio (HR) 0.33, 95% confidence intervals (CIs) 0.15-0.74; P = 0.007) and a not CRKp-targeted first-line treatment (HR 2.67, 95% CI 1.43-4.99; P = 0.002) were independent factors associated with an increased mortality in allo-SCT patients who developed a CRKp infection. Our study shows challenging findings of CRKp infections in SCT patients in Italy particularly after allo-SCT. The detection of carriers and the definition of early therapeutic strategies represent critical aspects of the management of CRKp infections after SCT. OI Aversa, Franco/0000-0002-8871-6817; de Fabritiis, Paolo/0000-0002-1835-0581; TIRINDELLI, MARIA CRISTINA/0000-0003-4645-4465; cudillo, laura/0000-0002-6828-9707

Published
2015

47. COLONIZZAZIONE ED INFEZIONE DA ENTEROBACTERIACEAE RESISTENTI AI CARBAPENEMICI NEI BAMBINI ITALIANI INTRATTAMENTO CON CHEMIOTERAPIA

Author

Caselli, D., Cesaro, Simone, Fagioli, F., Carraro, F., Ziino, O., Zanazzo, G., Meazza, C., Colombini, A., Muggeo, P. E., Mura, R., Orofino, M. G., Giacchino, M., La Spina, M., Consarino, C., Tucci, F., Barone, A., Cellini, M., Perruccio, K., Bandettini, R., Rondelli, R., De Masi, S., Aricò, M., and Castagnola, E. .

Subjects
antibiotico-resistenza, infezioni batteriche, sepsi, infezioni batteriche, antibiotico-resistenza, sepsi
Published
2015

48. Medical care related laboratory-confirmed bloodstream infections in paediatrics

Author

Virano, S, Scolfaro, C, Garazzino, S, De Intinis, C, Ghisetti, V, Raffaldi, I, Calitri, C, Tovo, Pa, Regina Margherita Children’s Hospital Bloodstream Infections Study Group including Plazzotta, C, Zotti, Cm, Neve, V, Conio, A, Vitale, P, Giacchino, M, Bertin, D, Carraro, F, Le Serre, D, Iannandrea, S, Grassitelli, Sm, Luccoli, L, Esposito, I, Ragazzi, P, Carlino, C, Porcellini, Mg, Bonaudo, R, Calvo, Pl, Baldi, M, Laudati, R, Ferraris, S, Aidala, E, Valori, A, Banaudi, E, Riggi, C, Bertino, E, Coscia, A, Di Nicola, P, Cavecchia, I, Cerchio, R, Bosetti, Fm, Bianciotto, M, Farina, D, and Manzoni, P

Subjects
Male, Methicillin-Resistant Staphylococcus aureus, Staphylococcus aureus, Drug Resistance, Anti-Bacterial Agents, Bacteremia, Child, Child, Preschool, Cross Infection, Drug Resistance, Multiple, Bacterial, Female, Hospitals, Pediatric, Hospitals, Teaching, Humans, Incidence, Infant, Infant, Newborn, Intensive Care Units, Pediatric, Italy, Prospective Studies, Risk Factors, Staphylococcal Infections, Pediatrics, Preschool, Pediatric, Teaching, Bacterial, Newborn, Hospitals, Intensive Care Units, Multiple
Abstract

The aim of this survey was to describe the incidence, epidemiology, microbiology, risk factors and outcome of medical care related laboratory-confirmed bloodstream infections (LCBIs) observed during a twelve-month prospective study in a Paediatric Teaching Hospital in Turin, Italy. Inclusion criteria were clinical signs of sepsis and positivity of one or more of the following tests: blood culture, polymerase chain reaction for bacterial and fungal DNA on blood, and culture on intravascular device tips. In all, 140 episodes of sepsis were documented in 131 children: 37 (26.4%) were healthcare outpatient-associated, 91 (65.0%) healthcare-associated and 12 (8.6%) community-acquired. The overall incidence of healthcare-associated LCBIs was 13.6/1,000 hospitalized patients and incidence density 1.4/1,000 inpatient days. The overall mortality was 3.9%. Forty-seven (36.7%) episodes involved newborns and 107 (83.6%) episodes were observed in children with an indwelling central venous catheter. Coagulase-negative staphylococci (26.8%), Staphylococcus aureus (15.2%), Escherichia coli (8.7%) and Candida spp. (7.2%) were responsible for the majority of cases. 9.5% of S. aureus isolates were methicillin-resistant and 6.5% of Gram negatives were extended-spectrum beta-lactamase-producing. Incidence and epidemiology of medical care related LCBIs were similar to the existing literature data. LCBIs caused by antibiotic-resistant microorganisms were fewer and mortality rate was lower. Most of the LCBIs recorded involved newborns and oncological children.

Published
2015

49. Note Illustrative della Carta Geologica d'Italia - Foglio 91 Chatillon

Author

Dal Piaz, GV, Gianotti, F, Monopoli, B, Pennacchioni, G, Tartarotti, P, Schiavo, A, Carraro, F, BISTACCHI, ANDREA LUIGI PAOLO, Massironi, M, Martin, S, Ratto, S., Dal Piaz, G, Gianotti, F, Monopoli, B, Pennacchioni, G, Tartarotti, P, Schiavo, A, Carraro, F, Bistacchi, A, Massironi, M, Martin, S, and Ratto, S

Subjects
GEO/03 - GEOLOGIA STRUTTURALE, Carta Geologica d'Italia
Published
2010

50. Stereotipi ed interessi professionali

Author

Ginevra, MC, Nota, L, Carraro, F, Ginevra, M, Nota, L, and Carraro, F

Subjects
stereotipi professionali, interessi professionali
Published
2010

Catalog

Books, media, physical & digital resources
See catalog results